AU3047299A - Methods of delivering glp-1 - Google Patents

Methods of delivering glp-1

Info

Publication number: AU3047299A
Authority: AU; Australia
Prior art keywords: methods; glp; delivering; delivering glp
Prior art date: 1998-04-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU30472/99A

Inventor

Bernard Thorens

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Isotis SA

Original Assignee

Modex Therapeutiques SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-13

Filing date

1999-04-13

Publication date

1999-11-01

1999-04-13 Application filed by Modex Therapeutiques SA filed Critical Modex Therapeutiques SA

1999-11-01 Publication of AU3047299A publication Critical patent/AU3047299A/en

Status Abandoned legal-status Critical Current

Links

101100337060 Caenorhabditis elegans glp-1 gene Proteins 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons

AU30472/99A 1998-04-13 1999-04-13 Methods of delivering glp-1 Abandoned AU3047299A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US8156298P	1998-04-13	1998-04-13
US60081562		1998-04-13
PCT/IB1999/000651 WO1999053064A2 (en)	1998-04-13	1999-04-13	Methods of delivering glp-1

Publications (1)

Publication Number	Publication Date
AU3047299A true AU3047299A (en)	1999-11-01

Family

ID=22164947

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU30472/99A Abandoned AU3047299A (en)	1998-04-13	1999-04-13	Methods of delivering glp-1

Country Status (2)

Country	Link
AU (1)	AU3047299A (en)
WO (1)	WO1999053064A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2500918T3 (en)	2001-12-21	2014-10-01	Human Genome Sciences, Inc.	Albumin and interferon beta fusion proteins
DK1767545T3 (en)	2005-09-22	2010-03-15	Biocompatibles Uk Ltd	GLP-1 (Glucagon-like Peptide-1) Fusion Polypeptides with Increased Peptidase Resistance
ATE444741T1 (en) *	2006-05-10	2009-10-15	Biocompatibles Uk Ltd	Spherical microcapsules containing GLP-1 peptides, their production and their use
EP2163243A1 (en) *	2008-09-12	2010-03-17	Biocompatibles UK Limited	Treatment of acute myocardial infarction (AMI) using encapsulated cells encoding and secreting GLP-1 peptides or analogs thereof
DK2344519T3 (en)	2008-11-07	2017-01-23	Massachusetts Gen Hospital	C-TERMINAL FRAGMENTS OF GLUCAGON SIMILAR PEPTID-1 (GLP-1)
US9040481B2 (en)	2010-11-02	2015-05-26	The General Hospital Corporation	Methods for treating steatotic disease
EP2729157B1 (en)	2011-07-06	2019-01-16	The General Hospital Corporation	A pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1) for use in treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5614492A (en) *	1986-05-05	1997-03-25	The General Hospital Corporation	Insulinotropic hormone GLP-1 (7-36) and uses thereof
CA2243718A1 (en) *	1996-02-06	1997-08-14	Eli Lilly And Company	Diabetes therapy

1999
- 1999-04-13 WO PCT/IB1999/000651 patent/WO1999053064A2/en active Application Filing
- 1999-04-13 AU AU30472/99A patent/AU3047299A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO1999053064A2 (en)	1999-10-21
WO1999053064A3 (en)	2000-03-16

Similar Documents

Publication	Publication Date	Title
AU6883798A (en)	1998-10-22	Method of anesthesia
AU1617399A (en)	1999-06-28	Glp-1 formulations
AU2610599A (en)	1999-09-15	N-terminally truncated glp-1 derivatives
AU3867400A (en)	2000-10-09	Methods of using bioelastomers
AU5954398A (en)	1998-10-01	Modified phytases
AU7389098A (en)	1998-12-08	Local anesthetic formulations
AU9790198A (en)	1999-04-27	Compounds and methods
AU6679198A (en)	1998-10-20	Methods for delivering bioactive agents
AU6513298A (en)	1998-10-12	Therapeutic compositions
AU4787697A (en)	1998-05-22	Therapeutic gene
AU5450399A (en)	2000-03-06	Pestivirus vaccination
AU3047299A (en)	1999-11-01	Methods of delivering glp-1
AU2542997A (en)	1997-10-17	Anesthetic method
AUPO565997A0 (en)	1997-04-10	Propanolamine derivatives
AUPO695497A0 (en)	1997-06-12	End of line pipeliner
AU2231997A (en)	1998-09-22	Formed artificial stone
AU7761498A (en)	1998-12-08	Algicides
AU8333998A (en)	1999-02-10	New use of nociceptin
AU1171099A (en)	1999-06-16	Therapeutic agents
AUPO937097A0 (en)	1997-10-16	Method
AUPO870297A0 (en)	1997-09-18	Method
AUPO982097A0 (en)	1997-11-06	Methods and compositions for use therein
AU7641098A (en)	1998-10-20	Therapeutic composition
AU6887198A (en)	1998-11-27	Improved method for the preparation of benzyluracils
AU4885397A (en)	1998-06-03	Aids therapeutic composition

Legal Events

Date	Code	Title	Description
2000-04-20	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase